These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8648528)

  • 61. Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae.
    Cheng MP; Bogoch II; Green K; Plevneshi A; Rudnick W; Shigayeva A; McGeer A; Lee TC;
    Clin Infect Dis; 2018 Apr; 66(8):1282-1285. PubMed ID: 29140429
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
    Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
    Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
    [No Abstract]   [Full Text] [Related]  

  • 63. Newer oral antimicrobials for resistant respiratory tract pathogens. Which show the most promise?
    Stein GE; Havlichek DH
    Postgrad Med; 1998 Jun; 103(6):67-70, 74-6. PubMed ID: 9633543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Penicillin-resistant pneumococci.
    Lancet; 1988 May; 1(8595):1142-3. PubMed ID: 2896962
    [No Abstract]   [Full Text] [Related]  

  • 65. [Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
    Odagiri S; Watanuki Y; Takahashi H; Shimada J
    Jpn J Antibiot; 2001 May; 54 Suppl B():22-4; discussion 25-7. PubMed ID: 12638138
    [No Abstract]   [Full Text] [Related]  

  • 66. Resistant Streptococcus pneumoniae in the community.
    Riley D; MacCulloch D; Morris AJ
    N Z Med J; 1997 Mar; 110(1040):107-8. PubMed ID: 9137315
    [No Abstract]   [Full Text] [Related]  

  • 67. Pneumococcal resistance in perspective: how well are we combating it?
    Amsden GW
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S125-8. PubMed ID: 14770075
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Upper respiratory tract infections in the child: suppurative otitis. The microbiologist's point of view].
    Murbach V
    Presse Med; 2002 Nov; 31(37 Pt 2):S21-2; discussion S24. PubMed ID: 12489331
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
    Collignon PJ; Bell JM
    Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Penicillin resistance is not equal to virulence: rational choice of antibiotics in pneumococcal infections.
    Lin TY
    Acta Paediatr Taiwan; 2003; 44(2):65-6. PubMed ID: 12845844
    [No Abstract]   [Full Text] [Related]  

  • 71. Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.
    Wang EE; Kellner JD; Arnold S
    Can Fam Physician; 1998 Sep; 44():1881-8. PubMed ID: 9789668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Are new antibiotics in therapy of respiratory tract infections necessary?].
    Haberl R; Wenisch C; Domej W
    Wien Med Wochenschr; 2003; 153(15-16):345-8. PubMed ID: 13677256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong.
    Ip M; Nelson EA; Cheuk ES; Sung RY; Li A; Ma H; Chan PK
    J Clin Microbiol; 2007 Jun; 45(6):1969-71. PubMed ID: 17409214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China.
    Zhao GM; Black S; Shinefield H; Wang CQ; Zhang YH; Lin YZ; Lu JL; Guo YF; Jiang QW
    Pediatr Infect Dis J; 2003 Aug; 22(8):739-42. PubMed ID: 12913778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
    Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
    Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increase in penicillin resistance of invasive Streptococcus pneumoniae in Brazil after 1999.
    Brandileone MC; Casagrande ST; Guerra ML; Zanella RC; de Andrade AL; Di Fabio JL
    J Antimicrob Chemother; 2005 Aug; 56(2):437-9. PubMed ID: 15972313
    [No Abstract]   [Full Text] [Related]  

  • 77. Strategies for stemming the tide of antimicrobial resistance.
    Low DE; Scheld WM
    JAMA; 1998 Feb; 279(5):394-5. PubMed ID: 9459476
    [No Abstract]   [Full Text] [Related]  

  • 78. Community prescribing and resistant Streptococcus pneumoniae.
    Barkai G; Greenberg D; Givon-Lavi N; Dreifuss E; Vardy D; Dagan R
    Emerg Infect Dis; 2005 Jun; 11(6):829-37. PubMed ID: 15963276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Penicillin-resistant pneumococci in southern Sweden, 1993-1997.
    Kamme C; Ekdahl K; Mölstad S
    Microb Drug Resist; 1999; 5(1):31-6. PubMed ID: 10332719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital.
    Doğan O; Gülmez D; Hasçelik G
    Microb Drug Resist; 2010 Mar; 16(1):39-41. PubMed ID: 19916790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.